The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants
Greater HbA1c variability was independently associated with increased risk of IS/SE and all-cause mortality among patients with AF, regardless of diabetic status.
Authors
- Mei‐Zhen Wu
- Anping Cai (ORCID: https://orcid.org/0000-0003-3953-5881)
- Christopher Tze Wei Tsang
- Jingnan Zhang (ORCID: https://orcid.org/0000-0002-4865-5212)
- Wenli Gu (ORCID: https://orcid.org/0000-0001-7162-6017)
- Ran Guo (ORCID: https://orcid.org/0000-0002-9424-8140)
- Jiayi Huang (ORCID: https://orcid.org/0000-0002-5153-506X)
- Ching-Yan Zhu
- Kai‐Hang Yiu
- Yik‐Ming Hung
- Gregory Y. H. Lip
Institutions
- University of Liverpool (GB)
- Queen Mary Hospital (CN)
- Liverpool Heart and Chest Hospital (GB)
- China Shenhua Energy (China) (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- University of Hong Kong (HK)
- Aalborg University (DK)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1093/eurjpc/zwae249
- Citations
- 5
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Queen Mary University of London
- Sanming Project of Medicine in Shenzhen